2 Biotech Stocks to Buy Hand Over Fist in February
To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...
IN8bio gains extension to meet Nasdaq listing requirements
IN8bio, Inc. (NASDAQ:INAB), a biotechnology firm specializing in cancer therapies, has been granted an additional 180 days to comply with Nasdaq's minimum bid price rule, as per a recent SEC filing.
U.S. Biomedical Leadership Threatened By NIH Licensing Guidelines
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
BridgeBio: Post Attruby Approval, Shares Don't Look Such Good Value - Rating Downgrade
BridgeBio could be an acquisition target, but current financial challenges and competition suggest a "Hold" rating until ...
Caprock Group LLC Invests $442,000 in iShares Biotechnology ETF (NASDAQ:IBB)
Caprock Group LLC purchased a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 3,344 ...
Stocktwits on MSN4d
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility
Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...
24/7 Wall St4d
2 Actively Managed ETFs That Got Smoked by the S&P 500 Last Year
Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years. However, ...
Zacks.com on MSN6d
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006.